Autres langues RenovoRx, Inc.

Actions

RNXT

US75989R1077

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 10/05/2024			Varia. 5j.	Varia. 1 janv.
1,45 ^USD	+7,81%		+18,85%	-36,68%

16/04	RenovoRx souligne la présentation récente d'un résumé de données cliniques lors de la réunion scientifique annuelle 2024 de la Society of Interventional Radiology (SIR)	CI
01/04	RenovoRx, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

RenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024	02/05
RenovoRx Regains Compliance with Nasdaq Stockholders Equity Requirement	19/04
RenovoRx Regains Compliance with Nasdaq Stockholders’ Equity Requirement	18/04
Autonomix Medical Inc Covered in Benzinga Article Highlighting Innovative Nerve Treatment Tech	16/04
RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting	16/04
RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting	16/04
RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026	15/04
RenovoRx, Inc. announced that it has received $11.136652 million in funding	15/04
RenovoRx Announces $11.1 Million at Market Private Placement	08/04
RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024	08/04
RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024	05/04
RenovoRx, Inc. announced that it expects to receive $11.136652 million in funding	04/04
RenovoRx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024	12/03
RenovoRx Highlights Key Leadership Promotions	11/03
RenovoRx Highlights Key Leadership Promotions	08/03
RenovoRx, Inc. Announces Executive Changes, Effective March 1, 2024	23/02
RenovoRx, Inc. Appoints Ronald B. Kocak as Principal Accounting and Financial Officer	09/02
RenovoRx, Inc. Announces Resignation of James Ahlers as Chief Financial Officer	09/02
RenovoRx CEO Issues Letter to Shareholders	06/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues RenovoRx, Inc.

Actions

RNXT

US75989R1077

Autres langues

Filtres